On February 5, 2026, Becton Dickinson & Co announced a reorganization into five business segments, effective October 1, 2025, which will streamline operations but did not affect existing product lines. The new segments are Medical Essentials, Connected Care, BioPharma Systems, Interventional, and Life Sciences, the latter to be eliminated following a merger with Waters Corporation.